vs

Side-by-side financial comparison of MERCURY GENERAL CORP (MCY) and ResMed (RMD). Click either name above to swap in a different company.

MERCURY GENERAL CORP is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× ResMed). ResMed runs the higher net margin — 27.6% vs 13.2%, a 14.4% gap on every dollar of revenue. On growth, MERCURY GENERAL CORP posted the faster year-over-year revenue change (12.4% vs 11.0%). Over the past eight quarters, MERCURY GENERAL CORP's revenue compounded faster (9.8% CAGR vs 7.9%).

Mercury General Corporation is a multiple-line insurance organization that offers personal automobiles, homeowners, renters, and business insurance. Mercury's primary focus is automobiles and homeowners' insurance.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

MCY vs RMD — Head-to-Head

Bigger by revenue
MCY
MCY
1.1× larger
MCY
$1.5B
$1.4B
RMD
Growing faster (revenue YoY)
MCY
MCY
+1.4% gap
MCY
12.4%
11.0%
RMD
Higher net margin
RMD
RMD
14.4% more per $
RMD
27.6%
13.2%
MCY
Faster 2-yr revenue CAGR
MCY
MCY
Annualised
MCY
9.8%
7.9%
RMD

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
MCY
MCY
RMD
RMD
Revenue
$1.5B
$1.4B
Net Profit
$202.5M
$392.6M
Gross Margin
99.7%
61.8%
Operating Margin
16.2%
34.6%
Net Margin
13.2%
27.6%
Revenue YoY
12.4%
11.0%
Net Profit YoY
100.4%
13.9%
EPS (diluted)
$3.66
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCY
MCY
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.5B
$1.4B
Q3 25
$1.6B
$1.3B
Q2 25
$1.5B
$1.3B
Q1 25
$1.4B
$1.3B
Q4 24
$1.4B
$1.3B
Q3 24
$1.5B
$1.2B
Q2 24
$1.3B
$1.2B
Net Profit
MCY
MCY
RMD
RMD
Q2 26
$392.6M
Q4 25
$202.5M
$392.6M
Q3 25
$280.4M
$348.5M
Q2 25
$166.5M
$379.7M
Q1 25
$-108.3M
$365.0M
Q4 24
$101.1M
$344.6M
Q3 24
$230.9M
$311.4M
Q2 24
$62.6M
$292.2M
Gross Margin
MCY
MCY
RMD
RMD
Q2 26
61.8%
Q4 25
99.7%
61.8%
Q3 25
99.8%
61.5%
Q2 25
99.8%
60.8%
Q1 25
99.7%
59.3%
Q4 24
99.7%
58.6%
Q3 24
99.8%
58.6%
Q2 24
99.8%
58.5%
Operating Margin
MCY
MCY
RMD
RMD
Q2 26
34.6%
Q4 25
16.2%
34.6%
Q3 25
22.1%
33.4%
Q2 25
14.0%
33.7%
Q1 25
-10.2%
33.0%
Q4 24
9.0%
32.5%
Q3 24
18.8%
31.6%
Q2 24
5.8%
31.2%
Net Margin
MCY
MCY
RMD
RMD
Q2 26
27.6%
Q4 25
13.2%
27.6%
Q3 25
17.7%
26.1%
Q2 25
11.3%
28.2%
Q1 25
-7.8%
28.3%
Q4 24
7.4%
26.9%
Q3 24
15.1%
25.4%
Q2 24
4.8%
23.9%
EPS (diluted)
MCY
MCY
RMD
RMD
Q2 26
$2.68
Q4 25
$3.66
$2.68
Q3 25
$5.06
$2.37
Q2 25
$3.01
$2.58
Q1 25
$-1.96
$2.48
Q4 24
$1.82
$2.34
Q3 24
$4.17
$2.11
Q2 24
$1.13
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCY
MCY
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$575.0M
$663.8M
Stockholders' EquityBook value
$2.4B
$6.3B
Total Assets
$9.6B
$8.5B
Debt / EquityLower = less leverage
0.24×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCY
MCY
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.2B
Q1 25
$932.7M
Q4 24
$521.9M
Q3 24
$426.4M
Q2 24
$238.4M
Total Debt
MCY
MCY
RMD
RMD
Q2 26
$663.8M
Q4 25
$575.0M
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$575.0M
$662.9M
Q3 24
$667.6M
Q2 24
$697.3M
Stockholders' Equity
MCY
MCY
RMD
RMD
Q2 26
$6.3B
Q4 25
$2.4B
$6.3B
Q3 25
$2.2B
$6.1B
Q2 25
$2.0B
$6.0B
Q1 25
$1.8B
$5.5B
Q4 24
$1.9B
$5.3B
Q3 24
$1.9B
$5.2B
Q2 24
$1.6B
$4.9B
Total Assets
MCY
MCY
RMD
RMD
Q2 26
$8.5B
Q4 25
$9.6B
$8.5B
Q3 25
$9.4B
$8.3B
Q2 25
$9.1B
$8.2B
Q1 25
$9.0B
$7.6B
Q4 24
$8.3B
$7.1B
Q3 24
$8.2B
$7.2B
Q2 24
$7.7B
$6.9B
Debt / Equity
MCY
MCY
RMD
RMD
Q2 26
0.11×
Q4 25
0.24×
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.30×
0.13×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCY
MCY
RMD
RMD
Operating Cash FlowLast quarter
$287.9M
Free Cash FlowOCF − Capex
$273.9M
FCF MarginFCF / Revenue
17.8%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
1.42×
TTM Free Cash FlowTrailing 4 quarters
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCY
MCY
RMD
RMD
Q2 26
Q4 25
$287.9M
$339.7M
Q3 25
$496.4M
$457.3M
Q2 25
$371.6M
$538.8M
Q1 25
$-68.7M
$578.7M
Q4 24
$248.3M
$308.6M
Q3 24
$318.1M
$325.5M
Q2 24
$278.0M
$440.1M
Free Cash Flow
MCY
MCY
RMD
RMD
Q2 26
Q4 25
$273.9M
$311.2M
Q3 25
$479.5M
$414.4M
Q2 25
$357.2M
$508.2M
Q1 25
$-81.9M
$557.9M
Q4 24
$236.0M
$288.0M
Q3 24
$306.2M
$307.7M
Q2 24
$266.5M
$415.2M
FCF Margin
MCY
MCY
RMD
RMD
Q2 26
Q4 25
17.8%
21.9%
Q3 25
30.3%
31.0%
Q2 25
24.2%
37.7%
Q1 25
-5.9%
43.2%
Q4 24
17.3%
22.5%
Q3 24
20.0%
25.1%
Q2 24
20.4%
33.9%
Capex Intensity
MCY
MCY
RMD
RMD
Q2 26
Q4 25
0.9%
2.0%
Q3 25
1.1%
3.2%
Q2 25
1.0%
2.3%
Q1 25
0.9%
1.6%
Q4 24
0.9%
1.6%
Q3 24
0.8%
1.5%
Q2 24
0.9%
2.0%
Cash Conversion
MCY
MCY
RMD
RMD
Q2 26
Q4 25
1.42×
0.87×
Q3 25
1.77×
1.31×
Q2 25
2.23×
1.42×
Q1 25
1.59×
Q4 24
2.46×
0.90×
Q3 24
1.38×
1.05×
Q2 24
4.44×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons